newsfilter
← Latest News
GlobeNewswire·

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

  • Conavi Medical Corp. will participate in Transcatheter Cardiovascular Therapeutics (TCT) 2026 from October 31–November 3, 2026, at the San Diego Convention Center.
  • This marks Conavi's first TCT appearance following U.S. FDA 510(k) clearance for its next-generation hybrid IVUS–OCT imaging system.
  • Dr. Megha Prasad will deliver a podium presentation titled "Detection of Post-Stent Medial Dissection and White Thrombus Using Hybrid IVUS OCT Imaging May Help Guide Management" on November 2, 2026, at 4:30 p.m. PT.
  • Dr. Megha Prasad will present an abstract titled "Saline-Based Hybrid IVUS–OCT Imaging: Feasibility of Contrast-Free Dual-Modality Intracoronary Imaging in a Porcine Model" on November 2, 2026, at 12:20 p.m. PT.
  • Conavi will lead two CRF Imaging Lab physician education sessions on November 3, 2026, focusing on acute coronary syndrome, calcium, hybrid imaging, left main/bifurcation disease, chronic total occlusion, & in-stent restenosis.
  • Conavi's hybrid technology combines IVUS depth with OCT high resolution to provide simultaneous, co-registered views of coronary arteries within a single system.
  • The company aims to introduce its cleared system to physicians & build relationships with potential clinical users to advance U.S. commercialization.